{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:54:07Z","timestamp":1793084047483,"version":"4.5.0"},"reference-count":24,"publisher":"The Journal of Rheumatology","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective.<\/jats:title>\n                    <jats:p>To assess differences in initial treatment and treatment response in male and female patients with rheumatoid arthritis (RA) in daily clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>The proportion of patients with RA starting different antirheumatic treatments (disease-modifying antirheumatic drugs; DMARD) and the response to treatment were compared in the international, observational METEOR register. All visits from start of the first DMARD until the first DMARD switch or the end of followup were selected. The effect of sex on time to switch from first to second treatment was calculated using Cox regression. Linear mixed model analyses were performed to assess whether men and women responded differently to treatments, as measured by Disease Activity Score (DAS) or Health Assessment Questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Women (n = 4393) more often started treatment with hydroxychloroquine, as monotherapy or in combination with methotrexate (MTX) or a glucocorticoid, and men (n = 1142) more often started treatment with MTX and\/or sulfasalazine. Time to switch DMARD was shorter for women than for men. Women had a statistically significantly higher DAS over time than men (DAS improvement per year \u03b2 \u22120.69, 95% CI \u22120.75 to \u22120.62 for men and \u22120.58, 95% CI \u22120.62 to \u22120.55 for women). Subanalyses per DMARD group showed for the conventional synthetic DMARD combination therapy a slightly greater decrease in DAS over time in men (\u22120.89, 95% CI \u22121.07 to \u22120.71) compared to women (\u22120.59, 95% CI \u22120.67 to \u22120.51), but these difference between the sexes were clinically negligible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion.<\/jats:title>\n                    <jats:p>This worldwide observational study suggests that in daily practice, men and women with RA are prescribed different initial treatments, but there were no differences in response to treatment between the sexes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.171176","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T07:25:23Z","timestamp":1529047523000},"page":"1361-1366","source":"Crossref","is-referenced-by-count":24,"title":["Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register"],"prefix":"10.3899","volume":"45","author":[{"given":"Sytske Anne","family":"Bergstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia F.","family":"Allaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ramiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimmisha","family":"Govind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e2ndida","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.M.","family":"Landew\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"key":"2018112909390549000_45.10.1361.1","first-page":"705","article-title":"Disability in rheumatoid arthritis: comparison of prognostic factors across three populations","volume":"14","author":"Sherrer","year":"1987","journal-title":"J Rheumatol"},{"key":"2018112909390549000_45.10.1361.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22120"},{"key":"2018112909390549000_45.10.1361.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.52.4.285"},{"key":"2018112909390549000_45.10.1361.4","first-page":"293","article-title":"Sex steroid receptors in rheumatoid arthritis","volume":"106","author":"Ishizuka","year":"2004","journal-title":"ClinSci"},{"key":"2018112909390549000_45.10.1361.5","first-page":"1809","article-title":"Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis","volume":"28","author":"Kuiper","year":"2001","journal-title":"J Rheumatol"},{"key":"2018112909390549000_45.10.1361.6","first-page":"10","article-title":"Adrenal and gonadal steroid hormone deficiency in the etiopathogenesis of rheumatoid arthritis","volume":"44","author":"Wilder","year":"1996","journal-title":"J Rheumatol Suppl"},{"key":"2018112909390549000_45.10.1361.7","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/ar2591","article-title":"Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study","volume":"11","author":"Sokka","year":"2009","journal-title":"Arthritis ResTher"},{"key":"2018112909390549000_45.10.1361.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel149"},{"key":"2018112909390549000_45.10.1361.9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110548"},{"key":"2018112909390549000_45.10.1361.10","first-page":"641","article-title":"Is long-term radiographic joint damage different between men and women? Prospective longitudinal data analysis of four early RA cohorts with greater than 15 years follow-up","volume":"34","author":"Asikainen","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909390549000_45.10.1361.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.056937"},{"key":"2018112909390549000_45.10.1361.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.7.667"},{"issue":"Suppl 101","key":"2018112909390549000_45.10.1361.13","first-page":"S87","article-title":"Ten years of METEOR (an international rheumatoid arthritis registry): development, research opportunities and future perspectives","volume":"5","author":"Bergstra","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909390549000_45.10.1361.14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.11.916"},{"key":"2018112909390549000_45.10.1361.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230202"},{"key":"2018112909390549000_45.10.1361.16","doi-asserted-by":"crossref","unstructured":"Schafer JL . Analysis of incomplete multivariate data. Boca Raton: Chapman & Hall\/CRC; 1997.","DOI":"10.1201\/9781439821862"},{"key":"2018112909390549000_45.10.1361.17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew048"},{"key":"2018112909390549000_45.10.1361.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.52.10.711"},{"key":"2018112909390549000_45.10.1361.19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0140-6736(90)90771-V","article-title":"Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up","volume":"335","author":"van der Heijde","year":"1990","journal-title":"Lancet"},{"key":"2018112909390549000_45.10.1361.20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1080\/14656566.2016.1197204","article-title":"Challenges and treatment options for rheumatoid arthritis during pregnancy","volume":"17","author":"Gerosa","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"2018112909390549000_45.10.1361.21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu176"},{"key":"2018112909390549000_45.10.1361.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.22640"},{"key":"2018112909390549000_45.10.1361.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6361.266"},{"key":"2018112909390549000_45.10.1361.24","first-page":"1972","article-title":"The limited value of the Health Assessment Questionnaire as an outcome measure in short term exercise trials","volume":"24","author":"van den Ende","year":"1997","journal-title":"J Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.171176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:21:52Z","timestamp":1751674912000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.171176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,1]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.3899\/jrheum.171176"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.171176","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]}}}